FDA May Refuse Imports From Indian Drug Company RPG
The Food and Drug Administration may refuse imports of drug products manufactured at two RPG Life Sciences facilities in India, the agency said in a May 28 warning letter. An FDA inspection at the company’s facility in Navi Mumbai allegedly…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
found current good manufacturing practice violations for active pharmaceutical ingredients. An inspection of RPG’s facility in Ankleshwar found violations of CGMP for finished pharmaceuticals, FDA said.